Abstract:The final, formatted version of the article will be published soon. You have multiple emails registered with Frontiers: Please enter your email address: If you already have an account, please login You don't have a Frontiers account ? You can register here Regarding the current need in predictive persisting models for Mycobacterium abscessus, we adopted the classical assay for studying drug-tolerant bacterial persisters, focusing on the behavior of a small mycobacterial antibiotic-insensitive subpopulation during prolonged exposure to moxifloxacin. Our study showed a widely ranging response of M. abscessus depending on the antibiotic concentration, the growth stage of mycobacterial cultures, and the availability of potassium ions in the medium. Middle logarithmic cultures, which were initially grown in the balanced or K + -free medium, contained small sup-populations to be competent for prolonged and stable survival in the presence of moxifloxacin. The response of mid-log cultures to the antibiotic attack involved killing with further re-growth upon exposure to 1 -2 MBCs of moxifloxacin or profound elimination of antibiotic insensitive subpopulation to < 10 2 CFU/mL in the presence of moxifloxacin at 16 MBCs. A stage when the number of viable survived cells was constant occurred for stationary-phase cultures grown in the complete medium and exposed to high moxifloxacin dose. On the contrary, antibiotic insensitive subpopulations in stationary-phase M. abscessus cultures that faced potassium deficiency underwent gradual killing during exposure to moxifloxacin in a wide concentration range (1 -16 MBCs). Electron microscopy studies demonstrated that singular cells were rapidly destructed after relatively short-term exposure to moxifloxacin, unlike cells in aggregates or clumps which disappeared afterwards and provided an explanation for the delayed biocidal effect. A small subpopulation that survived under harsh moxifloxacin pressure was remarkably heterogenous in cell morphology and fine structure and was composed of ovoid forms and cell-wall deficient cells with reduced size. The obtained results predict a possibility of distinct effects from the same antibiotic dose on M. abscessus cells depending on their physiological state and abundance in an infected cell or tissue. Taken together, our study may contribute to the development of strategies for combatting recalcitrant survivor subpopulations.

Antibacterial activity of the novel oxazolidinone contezolid (MRX-I) against Mycobacterium abscessus

A Novel Oxazolidinone, Contezolid (MRX-I), Expresses Anti-Mycobacterium abscessus Activity In Vitro

Antibacterial activity of the novel compound Sudapyridine (WX-081) against Mycobacterium abscessus

686. Evaluation of Contezolid Activity to Anaerobic and Gram-positive-cocci Isolates from a Phase 3 Acute Bacterial Skin and Skin Structure Infection Clinical Trial (MRX-I-06)

Evaluation of the Antibacterial Effect in Vitro of Moxifloxacin and Linezolid on Nontuberculous Mycobacterium.

Sitafloxacin Expresses Potent Anti-Mycobacterium abscessus Activity

Distribution of contezolid in different tissues of mice and human patients infected with Mycobacterium abscessus

Oral oxaborole MRX-5 exhibits efficacy against pulmonary Mycobacterium abscessus in mouse

Bactericidal and biofilm eradication efficacy of a fluorinated benzimidazole derivative, TFBZ, against methicillin-resistant Staphylococcus aureus

Assessment of Clofazimine and TB47 Combination Activity against Mycobacterium abscessus Using a Bioluminescent Approach

Drug Degradation Caused by mce3R Mutations Confers Contezolid (MRX-I) Resistance in Mycobacterium tuberculosis

Fate of in vitro cultured Mycobacterium abscessus populations when exposed to moxifloxacin

Contezolid in complicated skin and soft tissue infection

Antimicrobial and Antibiofilm Effects of Bithionol against Mycobacterium abscessus

Investigating the role of MAB_1915 in intrinsic resistance to multiple drugs in Mycobacterium abscessus

Azithromycin Exerts Bactericidal Activity and Enhances Innate Immune Mediated Killing of MDR Achromobacter xylosoxidans

Selection and Characterisation of Staphylococcus Aureus Mutants with Reduced Susceptibility to the Investigational Oxazolidinone MRX-I.

In vitro antimicrobial activity of doxycycline, minocycline, and tigecycline against Mycobacterium abscessus complex: A meta-analysis study

In Vitro Susceptibility of Nontuberculous Mycobacteria to Tedizolid

Triple-Antibiotic Combination Exerts Effective Activity against Mycobacterium avium subsp. hominissuis Biofilm and Airway Infection in an In Vivo Murine Model

Advances in contezolid: novel oxazolidinone antibacterial in Gram-positive treatment